Insider · CIK 0001192502

HALPRIN STEPHEN E

Reports to the SEC for 1 company · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001192502

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-09-12	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$7.50	+$75K	91,183
2014-09-12	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	−5,859 sh	$12.80	−$75K	85,324
2014-09-12	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · NonQualified Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	+10K sh	$7.50	+$75K	0
2013-06-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+3,496 sh	—	—	3,496
2013-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	77,687
2013-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2013-04-10	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.67	+$46.7K	77,519
2013-04-10	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$8.86	+$44.3K	82,519
2013-04-10	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	−6,499 sh	$14.00	−$91K	76,020
2013-04-10	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · NonQualified Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	+10K sh	$4.67	+$46.7K	0
2013-04-10	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · NonQualified Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	+5,000 sh	$8.86	+$44.3K	0
2012-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	67,519
2012-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2012-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$6.66	+$33.3K	85,000
2012-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2011-09-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.70	+$37K	55,852
2011-09-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$2.55	+$25.5K	65,852
2011-09-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−10K sh	$3.70	−$37K	0
2011-09-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−10K sh	$2.55	−$25.5K	0
2011-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	41,452
2011-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2011-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.77	+$28.8K	80,000
2011-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2011-03-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.50	+$35K	49,785
2011-03-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	−5,600 sh	$6.25	−$35K	44,185
2010-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.63	+$28.2K	95,000
2010-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2010-05-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	39,785
2010-05-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2010-03-24	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$5.81	+$58.1K	46,081
2010-03-24	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	−7,963 sh	$7.30	−$58.1K	38,118
2010-03-24	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	$5.81	−$58.1K	0
2010-03-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Non qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	$3.50	−$35K	0
2009-07-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	36,081
2009-07-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2009-05-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	$6.22	+$31.1K	90,000
2009-05-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award	Director	AAward	+1,667 sh	—	—	1,667
2009-04-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.50	+$35K	34,414
2009-04-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−10K sh	$3.50	−$35K	0
2008-07-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	$8.19	+$41K	95,000
2008-07-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award	Director	AAward	+1,667 sh	—	—	1,667
2007-06-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	$13.32	+$66.6K	105,000
2007-06-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award	Director	AAward	+1,667 sh	—	—	1,667
2007-06-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2007-06-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2006-06-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Common Stock (Right to Buy)A Award	Director	AAward	+5,000 sh	$8.86	+$44.3K	105,000
2006-06-15	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award	Director	AAward	+1,667 sh	$8.86	+$14.8K	1,667
2005-10-14	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Common Stock (Right to Buy)A Award	Director	AAward	+10K sh	$6.85	+$68.5K	100,000
2004-09-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (right to buy)A Award	Director	AAward	+10K sh	$7.50	+$75K	90,000
2004-04-08	LFCRLIFECORE BIOMEDICAL, INC. \DE\S Sale	Director	SSale	−5,800 sh	$8.60	−$49.9K	0

Recent filings

Accepted (ET)
Sep 164
LANDEC CORP \CA\0001437749-14-017112
SEC(opens sec.gov)
Jun 104
LANDEC CORP \CA\0001437749-13-007359
SEC(opens sec.gov)
May 204
HALPRIN STEPHEN E0001437749-13-006491
SEC(opens sec.gov)
Apr 124
HALPRIN STEPHEN E0001437749-13-004346
SEC(opens sec.gov)
May 234
HALPRIN STEPHEN E0001437749-12-005419
SEC(opens sec.gov)
May 184
HALPRIN STEPHEN E0001437749-12-005269
SEC(opens sec.gov)
Sep 274
HALPRIN STEPHEN E0001437749-11-007087
SEC(opens sec.gov)
May 274
HALPRIN STEPHEN E0001437749-11-003646
SEC(opens sec.gov)

Companies

LIFECORE BIOMEDICAL, INC. \DE\DirectorLFCR

Address

C/O LANDEC CORPORATION 3603 HAVEN AVENUE

MENLO PARK, CA, 94025